NCT04187833 2025-01-14Nivolumab in Combination With Talazoparib in Melanoma and Mutations in BRCA or BRCA-ness GenesCase Comprehensive Cancer CenterPhase 2 Completed8 enrolled 12 charts
NCT02921919 2022-08-24Open-Label Extension and Safety Study of TalazoparibPfizerPhase 2 Completed120 enrolled 16 charts